Login to Your Account

Financings Roundup

NPS Expects to Net $93M+ in Fourth Financing in 20 Months

By Tom Wall

Friday, April 15, 2011
NPS Pharmaceuticals Inc. expects to net $93 million in an underwritten public offering of 11 million shares at $9 a share, about a 2.6 percent discount over the previous day's closing price. It is the Bedminster, N.J.-company's fourth major financing in the past 20 months, for a total of more than $230 million during that period.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription